125 episodes

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice Oncology & Haematology Audio PeerVoice

    • Science
    • 5.0 • 1 Rating

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

    Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes?

    Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes?

    Visit https://www.peervoice.com/NHW860 to view the entire programme with slides. After completing “Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes?”, participants will be able to: Summarise the latest clinical data on adjuvant immunotherapy for resected melanoma; Describe the strengths and limitations of this evidence within the context of current clinical practice in the adjuvant treatment of resected melanoma; and Identify patients with resected melanoma who are at risk of recurrence.

    • 37 min
    Mohamad Mohty, MD, PhD - Veno-Occlusive Disease: Who to Treat, How to Treat, When to Treat

    Mohamad Mohty, MD, PhD - Veno-Occlusive Disease: Who to Treat, How to Treat, When to Treat

    Visit https://www.peervoice.com/VVJ860 to view the entire programme with slides. After completing “Mohamad Mohty, MD, PhD - Veno-Occlusive Disease: Who to Treat, How to Treat, When to Treat”, participants will be able to: Describe the clinical impact of sinusoidal obstruction syndrome (SOS)/veno-occlusive disease (VOD) and the factors associated with high risk for the development of SOS/VOD; Apply diagnostic and severity criteria to patients presenting with suspected SOS/VOD in order to establish an effective treatment plan; and Formulate practical strategies for the therapeutic management of patients at high risk of SOS/VOD.

    • 21 min
    Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022

    Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022

    Visit https://www.peervoice.com/GHN860 to view the entire programme with slides. After completing “Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022”, participants will be able to: Describe emerging data for targeted therapeutic strategies for management of patients with advanced non–small-cell lung cancer (NSCLC) and actionable mutations; Evaluate how these data add to current knowledge of the management of biomarker-positive advanced NSCLC; and Discuss the clinical implications of these data in the context of current advanced NSCLC treatment paradigms.

    • 23 min
    Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals

    Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals

    Visit https://www.peervoice.com/GJD860 to view the entire programme with slides. After completing “Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals”, participants will be able to: Propose the most appropriate sequence of life-prolonging agents, including radiopharmaceuticals, for patients with metastatic castration-resistant prostate cancer (mCRPC); Evaluate clinical trial data guiding the use of radiopharmaceuticals within the overall treatment paradigm for mCRPC; and Design holistic therapeutic regimens to maximise patient quality of life through optimisation of bone health and clear communication of treatment expectations.

    • 18 min
    Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC

    Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC

    Visit https://www.peervoice.com/CTP860 to view the entire programme with slides. After completing “Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC”, participants will be able to: Analyse the evidence supporting evolving standards of care in the contemporary management of nmCRPC and mHSPC; Design treatment regimens for patients with nmCRPC and mHSPC based on patient-specific considerations and pharmacologic characteristics of available therapeutic options; and Use practical approaches to overcome barriers to early treatment intensification and modern management of nmCRPC and mHSPC.

    • 1 hr 20 min
    Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice

    Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice

    Visit https://www.peervoice.com/YUS860 to view the entire programme with slides. After completing “Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice”, participants will be able to: Explain the rationale for targeting TROP2 in patients with advanced non–small-cell lung cancer (NSCLC); Assess current clinical data for TROP2-directed antibody-drug conjugates (ADCs) in the management of advanced NSCLC that has progressed on current standards of care; and Formulate optimal, evidence-based treatment plans that maximise long-term outcomes for patients with advanced NSCLC.

    • 24 min

Customer Reviews

5.0 out of 5
1 Rating

1 Rating

Top Podcasts In Science

Hidden Brain
Alie Ward
Sam Harris
CBS News Radio
Neil deGrasse Tyson
Mike Carruthers / OmniCast Media / Cumulus Podcast Network

You Might Also Like

More by PeerVoice

PeerVoice
PeerVoice
PeerVoice
PeerVoice
PeerVoice
PeerVoice